. 2019 Jul 15;8(8):1159–1167. doi: 10.1530/EC-19-0243
This work is licensed under a Table 3.
Correlation between serum concentration of fetuin-B with anthropometric and biochemical parameters in PCOS and control group.
| PCOS (n = 57) | Control (n = 51) | |
|---|---|---|
| BMI | r = 0.32, P = 0.01 | r = 0.33, P = 0.01 |
| Waist circumference | r = 0.30, P = 0.02 | r = 0.19, P = 0.16 |
| Fat mass (%) | r = 0.27, P = 0.04 | r = 0.12, P = 0.39 |
| Fat free mass (kg) | r = 0.14, P = 0.30 | r = 0.30, P = 0.02 |
| Baseline insulin | r = 0.36, P = 0.007 | r = 0.09, P = 0.6 |
| HOMA-IR | r = 0.31, P = 0.01 | r = 0.07, P = 0.6 |
| HOMA-B | r = 0.43, P = 0.01 | r = 0.66, P = 0.06 |
| TG | r = 0.30, P = 0.02 | r = 0.22, P = 0.12 |
| FAI | r = 0.26, P = 0.04 | r = 0.33, P = 0.01 |
| FLI | r = 0.29, P = 0.02 | r = 0.24, P = 0.08 |
| VAI | r = 0.29, P = 0.02 | r = 0.21, P = 0.13 |
| LAP | r = 0.32, P = 0.01 | r = 0.25, P = 0.69 |
Data are derived from Spearman’s rank correlation. The level of significance was accepted at P < 0.05.
FAI, free androgen index; FLI, fatty liver index; HOMA-B, homeostasis model assessment β cell function; HOMA-IR, homeostasis model assessment of insulin resistance; LAP, lipid accumulation product; PCOS, polycystic ovary syndrome; TG, triglycerides; VAI, visceral adiposity index.